175 related articles for article (PubMed ID: 26891067)
21. A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
Bedikian AY; Papadopoulos NE; Kim KB; Vardeleon A; Smith T; Lu B; Deitcher SR
Melanoma Res; 2008 Dec; 18(6):400-4. PubMed ID: 19011511
[TBL] [Abstract][Full Text] [Related]
22. A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Seegars MB; Woods R; Ellis LR; Bhave RR; Howard DS; Manuel M; Dralle S; Lyerly S; Powell BL; Pardee TS
J Hematol; 2021 Feb; 10(1):1-7. PubMed ID: 33643502
[TBL] [Abstract][Full Text] [Related]
23. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.
Trucco M; Barredo JC; Goldberg J; Leclerc GM; Hale GA; Gill J; Setty B; Smith T; Lush R; Lee JK; Reed DR
Pediatr Blood Cancer; 2018 Sep; 65(9):e27224. PubMed ID: 29856514
[TBL] [Abstract][Full Text] [Related]
24. Vincristine liposomal--INEX: lipid-encapsulated vincristine, onco TCS, transmembrane carrier system--vincristine, vincacine, vincristine sulfate liposomes for injection, VSLI.
Drugs R D; 2004; 5(2):119-23. PubMed ID: 15293876
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma.
Yang F; Jiang M; Lu M; Hu P; Wang H; Jiang J
Front Pharmacol; 2018; 9():991. PubMed ID: 30210349
[No Abstract] [Full Text] [Related]
26. Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Place AE; Pikman Y; Stevenson KE; Harris MH; Pauly M; Sulis ML; Hijiya N; Gore L; Cooper TM; Loh ML; Roti G; Neuberg DS; Hunt SK; Orloff-Parry S; Stegmaier K; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Jul; 65(7):e27062. PubMed ID: 29603593
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of liposomal vincristine.
Gelmon KA; Tolcher A; Diab AR; Bally MB; Embree L; Hudon N; Dedhar C; Ayers D; Eisen A; Melosky B; Burge C; Logan P; Mayer LD
J Clin Oncol; 1999 Feb; 17(2):697-705. PubMed ID: 10080616
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Thomas DA; Sarris AH; Cortes J; Faderl S; O'Brien S; Giles FJ; Garcia-Manero G; Rodriguez MA; Cabanillas F; Kantarjian H
Cancer; 2006 Jan; 106(1):120-7. PubMed ID: 16331634
[TBL] [Abstract][Full Text] [Related]
29. Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors.
McNall-Knapp RY; Williams CN; Reeves EN; Heideman RL; Meyer WH
Pediatr Blood Cancer; 2010 Jul; 54(7):909-15. PubMed ID: 20405511
[TBL] [Abstract][Full Text] [Related]
30. Are PEGylated liposomes better than conventional liposomes? A special case for vincristine.
Wang X; Song Y; Su Y; Tian Q; Li B; Quan J; Deng Y
Drug Deliv; 2016 May; 23(4):1092-100. PubMed ID: 26024386
[TBL] [Abstract][Full Text] [Related]
31. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.
Manley PE; Trippett T; Smith AA; Macy ME; Leary SES; Boklan J; Cohen KJ; Goldman S; Kilburn LB; Dhall G; Devin J; Herzog CE; Partap S; Fauchet F; Badreddine E; Bernard JP; Chi SN
Pediatr Blood Cancer; 2018 Sep; 65(9):e27217. PubMed ID: 29750396
[TBL] [Abstract][Full Text] [Related]
32. Vincristine: Can its therapeutic index be enhanced?
Moore A; Pinkerton R
Pediatr Blood Cancer; 2009 Dec; 53(7):1180-7. PubMed ID: 19588521
[TBL] [Abstract][Full Text] [Related]
33. Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature.
Pathak P; Hess R; Weiss MA
Ther Adv Hematol; 2014 Feb; 5(1):18-24. PubMed ID: 24490021
[TBL] [Abstract][Full Text] [Related]
34. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Krishna R; Webb MS; St Onge G; Mayer LD
J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
[TBL] [Abstract][Full Text] [Related]
35. FDA approves liposomal vincristine (Marqibo) for rare leukemia.
Oncology (Williston Park); 2012 Sep; 26(9):841. PubMed ID: 23061340
[No Abstract] [Full Text] [Related]
36. Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.
Moreno L; Casanova M; Chisholm JC; Berlanga P; Chastagner PB; Baruchel S; Amoroso L; Gallego Melcón S; Gerber NU; Bisogno G; Fagioli F; Geoerger B; Glade Bender JL; Aerts I; Bergeron C; Hingorani P; Elias I; Simcock M; Ferrara S; Le Bruchec Y; Slepetis R; Chen N; Vassal G
Eur J Cancer; 2018 Sep; 100():27-34. PubMed ID: 29936064
[TBL] [Abstract][Full Text] [Related]
37. Trial initiated for liposomal vincristine in relapsed/refractory acute lymphoblastic leukemia.
Oncology (Williston Park); 2006 Sep; 20(10):1292. PubMed ID: 17024874
[No Abstract] [Full Text] [Related]
38. Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach.
Moore AS; Norris R; Price G; Nguyen T; Ni M; George R; van Breda K; Duley J; Charles B; Pinkerton R
J Paediatr Child Health; 2011 Dec; 47(12):875-82. PubMed ID: 21658147
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of irinotecan administered on a weekly schedule in pediatric patients.
Bomgaars L; Kerr J; Berg S; Kuttesch J; Klenke R; Blaney SM
Pediatr Blood Cancer; 2006 Jan; 46(1):50-5. PubMed ID: 15768380
[TBL] [Abstract][Full Text] [Related]
40. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.
Frost BM; Lönnerholm G; Koopmans P; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Uges DR; de Graaf SS
Acta Paediatr; 2003 May; 92(5):551-7. PubMed ID: 12839283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
